✦ LIBER ✦

Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b

✍ Scribed by J. Toyota; I. Ozeki; Y. Karino; Y. Asahina; N. Izumi; S. Takahashi; Y. Kawakami; K. Chayama; N. Kamiya; K. Aoki; I. Yamada; Y. Suzuki; F. Suzuki; H. Kumada

Book ID: 119836610
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 309 KB
Volume: 20
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2012.01640.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, pharmacokinetics and resistant v

Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection

✍ I. Yamada; F. Suzuki; N. Kamiya; K. Aoki; Y. Sakurai; M. Kano; H. Matsui; H. Kum 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Factors associated with sustained virolo

Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype

✍ Abe, Hiroshi; Tsubota, Akihito; Shimada, Noritomo; Atsukawa, Masanori; Kato, Kei 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

757 OUTCOME OF PEGINTERFERON ALFA-2B AND

757 OUTCOME OF PEGINTERFERON ALFA-2B AND RIBAVIRIN THERAPY FOLLOWING MP-424 (TELAPREVIR) MONOTHERAPY FOR 24 WEEKS IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1B INFECTION

✍ O. Itaru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Impact of IL28B polymorphisms on 24-week

Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b

✍ Tsubota, Akihito; Shimada, Noritomo; Atsukawa, Masanori; Abe, Hiroshi; Kato, Kei 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Baseline factors and very early viral re

Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study

✍ Shimada, Noritomo; Toyoda, Hidenori; Tsubota, Akihito; Ide, Tatsuya; Takaguchi, 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 295 KB

Prediction of response to peginterferon-

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b

✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v